MediPharm Labs Corp. (OTCMKTS:MEDIF) is a Canada-based, GMP-certified cannabis extraction and purification company specializing in the development, manufacture and distribution of active pharmaceutical ingredients derived from cannabis and hemp. The company operates a state-of-the-art extraction facility in Barrie, Ontario, where it employs a proprietary low-temperature, low-pressure extraction process to produce high-purity distillates, isolates and full-spectrum extracts. MediPharm Labs serves a diverse customer base that includes pharmaceutical companies, consumer brands and licensed producers seeking reliable, scalable cannabinoid formulations.
The company’s product portfolio encompasses a range of oil-based and powdered cannabinoid preparations, including cannabidiol (CBD) and tetrahydrocannabinol (THC) distillates, cannabinoid isolations, nano-emulsions and custom-formulated lipid-based systems. MediPharm Labs also offers white-label and private-label manufacturing services, clinical trial support and analytical testing to ensure consistent potency, purity and stability. Its quality management practices adhere to current Good Manufacturing Practice (cGMP) standards, reinforcing the company’s commitment to pharmaceutical-grade output.
Founded in 2016, MediPharm Labs has grown from a single extraction line to multiple high-capacity production suites, expanding its reach into markets across Canada, Europe, Australia and select U.S. jurisdictions. The company holds controlled substance licenses issued by Health Canada and maintains strategic partnerships with international distributors to facilitate regulated market entry and compliance. MediPharm Labs continues to invest in research and development, leveraging its analytical laboratory to drive innovations in cannabinoid bioavailability, terpenoid profiling and novel delivery formats.
MediPharm Labs is guided by a leadership team with deep expertise in pharmaceuticals, biotechnology and consumer packaged goods. Its management group, comprised of seasoned professionals in regulatory affairs, quality assurance and product development, underscores a corporate philosophy centered on safety, efficacy and regulatory compliance. Under this stewardship, the company aims to support the evolving needs of patients, healthcare providers and consumer brands through scientifically driven cannabinoid solutions.
AI Generated. May Contain Errors.
Free MEDIF Stock Alerts